{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:09:14Z","timestamp":1791900554028,"version":"4.3.4"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/jid.2015.356","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T17:44:12Z","timestamp":1484675052000},"page":"24-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options"],"prefix":"10.1038","volume":"136","author":[{"given":"Michael","family":"Kasperkiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian D.","family":"Sadik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"Manz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1038\/JID.2015.356_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archdermatol.2010.317","article-title":"Congenital epidermolysis bullosa acquisita: vertical transfer of maternal autoantibody from mother to infant","volume":"147","author":"Abrams","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1038\/JID.2015.356_bib2","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1468-3083.2011.04205.x","article-title":"Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up","volume":"26","author":"Ahmed","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1038\/JID.2015.356_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/j.seminhematol.2012.04.001","article-title":"General aspects and mechanisms of peripheral neuropathy associated with bortezomib in patients with newly diagnosed multiple myeloma","volume":"49","author":"Broyl","year":"2012","journal-title":"Semin Hematol"},{"key":"10.1038\/JID.2015.356_bib4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2133.2011.10346.x","article-title":"The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy","volume":"165","author":"Buijsrogge","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1038\/JID.2015.356_bib5","first-page":"249","article-title":"FcRn: from molecular interactions to regulation of IgG pharmacokinetics and functions","volume":"382","author":"Challa","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1038\/JID.2015.356_bib6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2249.2006.03115.x","article-title":"Autoimmunity to type VII collagen in SKH1 mice is independent of regulatory T cells","volume":"145","author":"Chen","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/JID.2015.356_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/1523-1747.ep12285634","article-title":"Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita","volume":"108","author":"Chen","year":"1997","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.356_bib8","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.2353\/ajpath.2007.061212","article-title":"The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita","volume":"170","author":"Chen","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1038\/JID.2015.356_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/path.2157","article-title":"NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage","volume":"212","author":"Chiriac","year":"2007","journal-title":"J\u00a0Pathol"},{"key":"10.1038\/JID.2015.356_bib10","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1172\/JCI63089","article-title":"CXCR1\/2 inhibition enhances pancreatic islet survival after transplantation","volume":"122","author":"Citro","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1038\/JID.2015.356_bib11","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/mi.2012.134","article-title":"Inhibition of N-terminal ATPase on HSP90 attenuates colitis through enhanced Treg function","volume":"6","author":"Collins","year":"2013","journal-title":"Mucosal Immunol"},{"key":"10.1038\/JID.2015.356_bib12","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/jcmm.12338","article-title":"Blister-inducing antibodies target\u00a0multiple epitopes on collagen VII in mice","volume":"18","author":"Csorba","year":"2014","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1038\/JID.2015.356_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2230.2010.03845.x","article-title":"Clinical and immunopathological evaluation of epidermolysis bullosa acquisita","volume":"36","author":"Delgado","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1038\/JID.2015.356_bib14","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1128\/MCB.05155-11","article-title":"Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells","volume":"31","author":"de Zoeten","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1038\/JID.2015.356_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/CE.S39770","article-title":"Mavrilimumab: an evidence-based review of its potential in the treatment of rheumatoid arthritis","volume":"9","author":"Di Franco","year":"2014","journal-title":"Core Evid"},{"key":"10.1038\/JID.2015.356_bib16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/1523-1747.ep12470317","article-title":"Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated","volume":"91","author":"Gammon","year":"1988","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.356_bib17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/1523-1747.ep12472291","article-title":"Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain","volume":"100","author":"Gammon","year":"1993","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.356_bib18","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1016\/S1470-2045(13)70169-4","article-title":"Inhibition of HSP90 molecular chaperones: moving into the clinic","volume":"14","author":"Garcia-Carbonero","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1038\/JID.2015.356_bib19","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.4049\/jimmunol.1100796","article-title":"Complement-fixing anti-type\u00a0VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice","volume":"187","author":"Hammers","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1038\/JID.2015.356_bib20","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/jid.2013.91","article-title":"Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation","volume":"133","author":"Hellberg","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.356_bib21","first-page":"5","article-title":"The allosteric CXCR1\/2 inhibitor DF2156A improves experimental epidermolysis bullosa acquisita","volume":"S3","author":"Hirose","year":"2013","journal-title":"J\u00a0Genet Syndr Gene Ther"},{"key":"10.1038\/JID.2015.356_bib22","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/jid.2014.453","article-title":"Effects of intravenous immunoglobulins on mice with experimental epidermolysis bullosa acquisita","volume":"135","author":"Hirose","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.356_bib23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jaut.2012.04.002","article-title":"Enzymatic autoantibody glycan hydrolysis alleviates autoimmunity against type VII collagen","volume":"39","author":"Hirose","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1038\/JID.2015.356_bib24","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1084\/jem.178.5.1617","article-title":"Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction","volume":"178","author":"Ierino","year":"1993","journal-title":"J\u00a0Exp Med"},{"key":"10.1038\/JID.2015.356_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12016-009-8153-y","article-title":"High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases","volume":"38","author":"Ishii","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1038\/JID.2015.356_bib26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/path.2857","article-title":"Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita","volume":"224","author":"Ishii","year":"2011","journal-title":"J\u00a0Pathol"},{"key":"10.1038\/JID.2015.356_bib27","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.2174\/1381612821666150316122502","article-title":"Animal models to investigate pathomechanisms and evaluate novel treatments for autoimmune bullous dermatoses","volume":"21","author":"Iwata","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1038\/JID.2015.356_bib28","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.4049\/jimmunol.1300310","article-title":"B\u00a0cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita","volume":"191","author":"Iwata","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1038\/JID.2015.356_bib29","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/jid.2014.451","article-title":"Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita","volume":"135","author":"Iwata","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.356_bib30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"10.1038\/JID.2015.356_bib31","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/nm.2862","article-title":"Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of Fc\u03b3RIIB and dectin-1","volume":"18","author":"Karsten","year":"2012","journal-title":"Nat Med"},{"key":"10.1038\/JID.2015.356_bib32","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1365-2133.2010.09680.x","article-title":"Clearance rates of circulating and\u00a0tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita","volume":"162","author":"Kasperkiewicz","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1038\/JID.2015.356_bib33","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1182\/blood-2010-10-314609","article-title":"Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets","volume":"117","author":"Kasperkiewicz","year":"2011","journal-title":"Blood"},{"key":"10.1038\/JID.2015.356_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/path.4023","article-title":"Genetic identification and functional validation of Fc\u03b3RIV as key molecule in autoantibody-induced tissue injury","volume":"228","author":"Kasperkiewicz","year":"2012","journal-title":"J\u00a0Pathol"},{"key":"10.1038\/JID.2015.356_bib35","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/eji.201444769","article-title":"Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita","volume":"45","author":"Kasprick","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1038\/JID.2015.356_bib36","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1111\/j.1468-3083.2012.04617.x","article-title":"Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions","volume":"27","author":"Kim","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1038\/JID.2015.356_bib37","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.jaad.2011.12.032","article-title":"Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita","volume":"68","author":"Komorowski","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1038\/JID.2015.356_bib38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/path.2973","article-title":"Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita","volume":"225","author":"Kopecki","year":"2011","journal-title":"J\u00a0Pathol"},{"key":"10.1038\/JID.2015.356_bib39","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.biocel.2007.04.011","article-title":"Flightless I: an actin-remodelling protein and an important negative regulator of wound repair","volume":"40","author":"Kopecki","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1038\/JID.2015.356_bib40","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/jid.2012.457","article-title":"Topically applied flightless I neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita","volume":"133","author":"Kopecki","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.356_bib41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/path.4323","article-title":"Flightless I over-expression impairs skin barrier development, function and recovery following skin blistering","volume":"232","author":"Kopecki","year":"2014","journal-title":"J\u00a0Pathol"},{"key":"10.1038\/JID.2015.356_bib42","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1084\/jem.20132496","article-title":"The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in\u00a0vivo inflammatory environment without a direct role in leukocyte recruitment","volume":"211","author":"Kov\u00e1cs","year":"2014","journal-title":"J\u00a0Exp Med"},{"key":"10.1038\/JID.2015.356_bib43","doi-asserted-by":"crossref","first-page":"ra23","DOI":"10.1126\/scisignal.2001617","article-title":"PI3K\u03b2 plays a critical role in neutrophil activation by immune complexes","volume":"4","author":"Kulkarni","year":"2011","journal-title":"Sci Signal"},{"key":"10.1038\/JID.2015.356_bib44","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1172\/JCI116774","article-title":"Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa","volume":"92","author":"Lapiere","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1038\/JID.2015.356_bib45","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1172\/JCI24394","article-title":"Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases","volume":"115","author":"Li","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1038\/JID.2015.356_bib46","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.4049\/jimmunol.1000667","article-title":"Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model","volume":"185","author":"Li","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1038\/JID.2015.356_bib47","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/jid.2011.466","article-title":"Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita","volume":"132","author":"Ludwig","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.356_bib48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/jid.2010.248","article-title":"Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita","volume":"131","author":"Ludwig","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.356_bib49","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/archderm.135.8.954","article-title":"Mucosal morbidity in patients with epidermolysis bullosa acquisita","volume":"135","author":"Luke","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1038\/JID.2015.356_bib50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1744-9987.2012.01075.x","article-title":"Immunoadsorption in dermatology","volume":"16","author":"Meyersburg","year":"2012","journal-title":"Ther Apher Dial"},{"key":"10.1038\/JID.2015.356_bib51","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.4049\/jimmunol.178.10.6514","article-title":"The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita","volume":"178","author":"Mihai","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1038\/JID.2015.356_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.clim.2009.12.010","article-title":"T\u00a0and B cells target identical regions of the non-collagenous domain 1 of type VII collagen in epidermolysis bullosa acquisita","volume":"135","author":"M\u00fcller","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1038\/JID.2015.356_bib53","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1763","article-title":"The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis","volume":"14","author":"Neubert","year":"2008","journal-title":"Nat Med"},{"key":"10.1038\/JID.2015.356_bib54","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/archderm.143.2.192","article-title":"Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies)","volume":"143","author":"Niedermeier","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1038\/JID.2015.356_bib55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/cei.12488","article-title":"A\u00a0pilot study on reparixin, a CXCR1\/2 antagonist, to assess safety and efficacy in attenuating ischaemia-reperfusion injury and inflammation after on-pump coronary artery bypass graft surgery","volume":"180","author":"Opfermann","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/JID.2015.356_bib56","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.2194","article-title":"B\u00a0cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen","volume":"13","author":"Puga","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1038\/JID.2015.356_bib57","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jaut.2009.11.003","article-title":"Pathogenicity of IgG subclass autoantibodies to type VII collagen: induction of dermal-epidermal separation","volume":"34","author":"Recke","year":"2010","journal-title":"J\u00a0Autoimmun"},{"key":"10.1038\/JID.2015.356_bib58","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.4049\/jimmunol.1400160","article-title":"Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex\u00a0vivo","volume":"193","author":"Recke","year":"2014","journal-title":"J\u00a0Immunol"},{"issue":"Suppl 5","key":"10.1038\/JID.2015.356_bib59","doi-asserted-by":"crossref","first-page":"v38","DOI":"10.1093\/rheumatology\/kes114","article-title":"Assessing the safety of biologic agents in patients with\u00a0rheumatoid arthritis","volume":"51","author":"Rubbert-Roth","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1038\/JID.2015.356_bib60","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.4049\/jimmunol.1402688","article-title":"Caspase-1-independent IL\u20131 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules","volume":"194","author":"Sadeghi","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1038\/JID.2015.356_bib61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/path.4556","article-title":"The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita","volume":"237","author":"Sadeghi","year":"2015","journal-title":"J\u00a0Pathol"},{"key":"10.1038\/JID.2015.356_bib62","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jdermsci.2011.03.003","article-title":"Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients","volume":"62","author":"Saleh","year":"2011","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1038\/JID.2015.356_bib63","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/annrheumdis-2012-203116","article-title":"Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis","volume":"73","author":"Salgado","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/JID.2015.356_bib64","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4049\/jimmunol.1301556","article-title":"GM-CSF modulates autoantibody production and skin blistering in experimental epidermolysis bullosa acquisita","volume":"192","author":"Samavedam","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1038\/JID.2015.356_bib65","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2012.08.002","article-title":"Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction","volume":"40","author":"Samavedam","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1038\/JID.2015.356_bib66","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/archderm.142.2.147","article-title":"Successful adjuvant treatment of\u00a0recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab","volume":"142","author":"Schmidt","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1038\/JID.2015.356_bib67","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12016-007-8021-6","article-title":"Rituximab in treatment-resistant\u00a0autoimmune blistering skin disorders","volume":"34","author":"Schmidt","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1038\/JID.2015.356_bib68","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1038\/JID.2015.356_bib69","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1750-1172-8-93","article-title":"Metabolite analysis distinguishes between mice with epidermolysis bullosa acquisita and healthy mice","volume":"8","author":"Sch\u00f6nig","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1038\/JID.2015.356_bib70","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.ajpath.2014.05.007","article-title":"Fc\u03b3 receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid","volume":"184","author":"Schulze","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1038\/JID.2015.356_bib71","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/eji.201344230","article-title":"Broad requirement for terminal sialic\u00a0acid residues and Fc\u03b3RIIB for the preventive and therapeutic activity of intravenous immunoglobulins in\u00a0vivo","volume":"44","author":"Schwab","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1038\/JID.2015.356_bib72","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: how does IgG modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/JID.2015.356_bib73","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00109-008-0366-7","article-title":"Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita","volume":"86","author":"Sesarman","year":"2008","journal-title":"J\u00a0Mol Med"},{"key":"10.1038\/JID.2015.356_bib74","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2133.2007.08388.x","article-title":"Binding of avian IgY to type\u00a0VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice","volume":"158","author":"Sesarman","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1038\/JID.2015.356_bib75","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/path.1674","article-title":"Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid","volume":"204","author":"Shimanovich","year":"2004","journal-title":"J\u00a0Pathol"},{"key":"10.1038\/JID.2015.356_bib76","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.4049\/jimmunol.0901412","article-title":"T\u00a0cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita","volume":"184","author":"Sitaru","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1038\/JID.2015.356_bib77","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.4049\/jimmunol.177.5.3461","article-title":"Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice","volume":"177","author":"Sitaru","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1038\/JID.2015.356_bib78","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0002-9440(10)64182-X","article-title":"Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin","volume":"161","author":"Sitaru","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1038\/JID.2015.356_bib79","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI200521386","article-title":"Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen","volume":"115","author":"Sitaru","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1038\/JID.2015.356_bib80","first-page":"907","article-title":"Hsp90 inhibitor as a sensitizer of cancer cells to different therapies (review)","volume":"46","author":"Sol\u00e1rov\u00e1","year":"2015","journal-title":"Int J Oncol"},{"key":"10.1038\/JID.2015.356_bib81","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1038\/ncomms3462","article-title":"Genome-wide mapping of gene-microbiota interactions in susceptibility to autoimmune skin blistering","volume":"4","author":"Srinivas","year":"2013","journal-title":"Nat Commun"},{"key":"10.1038\/JID.2015.356_bib82","doi-asserted-by":"crossref","first-page":"e83631","DOI":"10.1371\/journal.pone.0083631","article-title":"Persistent autoantibody-production by intermediates between short-and long-lived plasma cells in inflamed lymph nodes of experimental epidermolysis bullosa acquisita","volume":"8","author":"Tiburzy","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/JID.2015.356_bib83","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/exd.12476","article-title":"Immunomodulatory effects of heat shock protein 90 inhibition on humoral immune responses","volume":"23","author":"Tukaj","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1038\/JID.2015.356_bib84","first-page":"10","article-title":"Inhibitory effects of heat shock protein 90 blockade on proinflammatory human Th1 and Th17 cell subpopulations","volume":"11","author":"Tukaj","year":"2014","journal-title":"J\u00a0Inflamm"},{"key":"10.1038\/JID.2015.356_bib85","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s12192-014-0513-8","article-title":"Hsp90 blockade modulates bullous pemphigoid IgG-induced IL\u20138 production by keratinocytes","volume":"19","author":"Tukaj","year":"2014","journal-title":"Cell Stress Chaperones"},{"key":"10.1038\/JID.2015.356_bib86","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/exd.12680","article-title":"Heat shock protein 90 is required for ex\u00a0vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita","volume":"24","author":"Tukaj","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1038\/JID.2015.356_bib87","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/exd.12760","article-title":"Heat shock protein 90: a pathophysiological factor and novel treatment target in autoimmune bullous skin diseases","volume":"24","author":"Tukaj","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1038\/JID.2015.356_bib88","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/exd.12011","article-title":"Evidence for pathogenicity of autoreactive T cells in autoimmune bullous diseases shown by animal disease models","volume":"21","author":"Ujiie","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1038\/JID.2015.356_bib89","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ni.2511","article-title":"Innate B cell helpers reveal novel types of antibody responses","volume":"14","author":"Vinuesa","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1038\/JID.2015.356_bib90","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/jid.2015.51","article-title":"Autoantibodies to multiple epitopes on the non-collagenous-1 domain of type VII collagen induce blisters","volume":"135","author":"Vorobyev","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.356_bib91","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2353\/ajpath.2010.090744","article-title":"Blockade of autoantibody-initiated tissue damage by using recombinant fab antibody fragments against pathogenic autoantigen","volume":"176","author":"Wang","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1038\/JID.2015.356_bib92","first-page":"S7","article-title":"Type IV collagen binding-site within type VII collagen is a pathogenic epitope for EBA autoantibodies","volume":"131","author":"Wang","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.356_bib93","doi-asserted-by":"crossref","first-page":"E1297","DOI":"10.1073\/pnas.1422481112","article-title":"Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity","volume":"112","author":"Washburn","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/JID.2015.356_bib94","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1074\/jbc.M113.531327","article-title":"The cysteine-rich region of type\u00a0VII collagen\u00a0is a cystine knot with a new topology","volume":"289","author":"Wegener","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1038\/JID.2015.356_bib95","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJM198404193101602","article-title":"Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita","volume":"310","author":"Woodley","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1038\/JID.2015.356_bib96","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI113373","article-title":"Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen","volume":"81","author":"Woodley","year":"1988","journal-title":"J\u00a0Clin Invest"},{"key":"10.1038\/JID.2015.356_bib97","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.0022-202X.2005.23702.x","article-title":"Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita","volume":"124","author":"Woodley","year":"2005","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.356_bib98","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.jid.5700254","article-title":"Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients","volume":"126","author":"Woodley","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.356_bib99","doi-asserted-by":"crossref","first-page":"e85317","DOI":"10.1371\/journal.pone.0085317","article-title":"EndoS reduces the pathogenicity of anti-mCOL7 IgG through reduced binding of immune complexes to neutrophils","volume":"9","author":"Yu","year":"2014","journal-title":"PLoS One"},{"key":"10.1038\/JID.2015.356_bib100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrclinonc.2014.83","article-title":"The clinical development of MEK inhibitors","volume":"11","author":"Zhao","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1038\/JID.2015.356_bib101","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1038\/jid.2011.231","article-title":"Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita","volume":"131","author":"Zumelzu","year":"2011","journal-title":"J\u00a0Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15000068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15000068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T02:55:57Z","timestamp":1601348157000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15000068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0022202X15000068"],"URL":"https:\/\/doi.org\/10.1038\/jid.2015.356","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1038\/JID.2015.356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}